SEL1L Plays a Major Role in Human Malignant Gliomas.
Authors of this article are:
Mellai M, Annovazzi L, Boldorini R, Bertero L, Cassoni P, De Blasio P, Biunno I, Schiffer D.
A summary of the article is shown below:
Suppressor of Lin-12-like (C. elegans) (SEL1L) participates in the endoplasmic reticulum-associated protein degradation pathway, malignant transformation and stem cell biology. We explored the role of SEL1L in 110 adult gliomas, of different molecular subtype and grade, in relation to cell proliferation, stemness, glioma-associated microglia/macrophages (GAMs), prognostic markers and clinical outcome. SEL1L protein expression was assessed by immunohistochemistry and Western blotting. Genetic and epigenetic alterations were detected by molecular genetics techniques. SEL1L was overexpressed in anaplastic gliomas (WHO grade III) and in glioblastoma (GB, WHO grade IV) with the highest labelling index in the latter. Immunoreactivity was significantly associated with histological grade (P = 0.002) and cell proliferation index Ki-67/MIB-1 (P = 0.0001). In GB, SEL1L co-localised with stemness markers Nestin and Sox2. Endothelial cells and vascular pericytes of proliferative tumour blood vessels expressed SEL1L suggesting a role in tumour neo-vasculature. GAMs consistently expressed SEL1L. SEL1L overexpression was significantly associated with TERT promoter mutations (P = 0.0001), EGFR gene amplification (P = 0.0013), LOH on 10q (P = 0.0012) but was mutually exclusive with IDH1/2 mutations (P = 0.0001). SEL1L immunoreactivity correlated with tumour progression and cell proliferation, conditioning poor patient survival and response to therapy. This study emphasises SEL1L as a potential biomarker for the most common subgroup of TERT mutant / EGFR amplified / IDH-wild type GBs. This article is protected by copyright. All rights reserved.This article is protected by copyright. All rights reserved.
Check out the article’s website on Pubmed for more information:
This article is a good source of information and a good way to become familiar with topics such as: Brain tumours; Glioblastoma; Microglia/macrophages; Prognosis; SEL1L.